David Henry's JCSO podcast, February 2016

For the February podcast for The Journal of Community and Supportive Oncology, Editor-in-Chief Dr David Henry examines two Original Reports, one on a collaborative investigation by scientists and members of a social network into fluoroquinolone-related neuropsychiatric and mitochondrial toxicity and another on the prognostic value of complete remission with superior platelet counts in patients with acute myeloid leukemia. The Case Reports this month focus on rare tumors: in one case, it is a metastatic primary bladder adenocarcinoma for which a novel treatment approach prolonged survival; and in a second, an 18-year follow-up on a rare, indolent form of T-cell prolymphocytic leukemia. The Community Translations column features the novel MEK inhibitor, cobimetinib, which was approved last year in combination with the BRAF inhibitor, vemurafenib, for metastatic melanoma with BRAF V600E or V600K mutation. Dr Henry also discusses articles on new therapies for gastrointestinal cancers and on selected practice-changing presentations from the 2015 annual meeting of the San Antonio Breast Cancer Symposium in Orlando last year.

You can listen to David Henry's JCSO podcast, February 2016 online on Radio and Podcast. Open the player on this page to stream the available audio.

David Henry's JCSO podcast, February 2016 is an episode from David Henry's JCSO Podcast by David Henry’s JCSO Podcast.

This episode is 00:07:34 long.

This episode was published on Feb 1, 2016.

Yes. Use the heart button on the episode page to add it to your favorite episodes list.

Yes. This page shows related episodes from David Henry's JCSO Podcast when more episodes are available from the podcast feed.